Hipertensión portal idiopática no cirrótica

Turon, Fanny; Silva-Junior, Gilberto; Hernandez-Gea, Virginia; Garcia-Pagan, Juan Carlos.
Gastroenterol. hepatol. (Ed. impr.) ; 38(9): 556-562, nov. 2015. ilus
Artículo en Español | IBECS (España) | ID: ibc-143420

Documentos relacionados

  1. Influence of gastroesophageal flap valve on esophageal variceal bleeding in patients with liver cirrhosis.
  2. [Follow-up study of 116 cases of transjugular intrahepatic portosystemic shunt in the treatment of cirrhotic portal hypertension].
  3. Triage policy to postpone endoscopy for patients with low-risk varices is safe during the lockdown period of COVID-19 pandemic.
  4. Transjugular intrahepatic portosystemic shunt (TIPS) in Spain. Clinical-epidemiological considerations in relation to a multicenter registry.
  5. Thirty-Day Readmission After Esophageal Variceal Hemorrhage and its Impact on Outcomes in the United States.
  6. Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients.
  7. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
  8. Increased Prevalence of Left Lobe Atrophy in Long-standing Extrahepatic Portal Vein Obstruction.
  9. Low Risk of Variceal Bleeding Among Subjects With Cirrhosis Treated With Electroconvulsive Therapy: A Nationwide Study.
  10. The clinical impact of splenic artery ligation on the occurrence of digestive varices after pancreaticoduodenectomy with combined portal vein resection: a retrospective study in two institutes.